Literature DB >> 15198869

Influence of cerebral oxygenation following severe head injury on neuropsychological testing.

J Meixensberger1, C Renner, R Simanowski, A Schmidtke, J Dings, K Roosen.   

Abstract

Despite recent advances in the management of severe head injury the mortality and morbidity remains high. Intracranial pressure (ICP) and cerebral perfusion pressure (CPP) are crucial parameters for the correct management at the intensive care unit, due to their therapeutic and prognostic importance. In addition, regional brain tissue oxygenation (ptiO2) seems to be of importance. While different studies demonstrated the impact of cerebral hypoxia on outcome (mortality), no data are available focusing on morbidity (neuropsychological deficits). Therefore, our study is carried out to demonstrate a possible relationship between amount of cerebral oxygenation during acute stage after severe head injury and neuropsychological outcome. Besides ICP and CPP, ptiO2 was monitored in 40 severely head injured patients during the ICU stay from the day of admission until day 10. Monitoring data were stored and amount of hypoxic episodes were calculated. Besides outcome using the Glasgow Outcome Scale neuropsychological testing was performed 2-3 years after injury. Analysing the quality of brain tissue oxygenation, a relationship to the performance in neuropsychological tests could be found. Patients with low brain tissue oxygenation had a worse outcome in neuropsychological testing, especially concerning intelligence and memory. Associated with these deficits patients showed a reduced performance in their profession. Our data suggest a possible predictive value of brain tissue oxygen on morbidity analysing neurocognitive function after head injury. This may implicate monitoring and treatment of cerebral hypoxia. Copyright 2004 W.S. Maney and Son Ltd

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15198869     DOI: 10.1179/016164104225014094

Source DB:  PubMed          Journal:  Neurol Res        ISSN: 0161-6412            Impact factor:   2.448


  8 in total

Review 1.  Direct cerebral oxygenation monitoring--a systematic review of recent publications.

Authors:  Erhard W Lang; Jamin M Mulvey; Yugan Mudaliar; Nicholas W C Dorsch
Journal:  Neurosurg Rev       Date:  2007-01-13       Impact factor: 3.042

2.  Comparison between cerebral tissue oxygen tension and energy metabolism in experimental subdural hematoma.

Authors:  Troels Halfeld Nielsen; Susanne I Engell; Rikke Aagaard Johnsen; Mette K Schulz; Oke Gerke; Jacob Hjelmborg; Palle Toft; Carl-Henrik Nordström
Journal:  Neurocrit Care       Date:  2011-12       Impact factor: 3.210

3.  Anemia is associated with metabolic distress and brain tissue hypoxia after subarachnoid hemorrhage.

Authors:  Pedro Kurtz; J Michael Schmidt; Jan Claassen; Emmanuel Carrera; Luis Fernandez; Raimund Helbok; Mary Presciutti; R Morgan Stuart; E Sander Connolly; Neeraj Badjatia; Stephan A Mayer; Kiwon Lee
Journal:  Neurocrit Care       Date:  2010-08       Impact factor: 3.210

4.  Cerebral perfusion pressure and brain ischaemia: can one size fit all?

Authors:  Peter J D Andrews
Journal:  Crit Care       Date:  2005-11-22       Impact factor: 9.097

5.  Low brain oxygenation and differences in neuropsychological outcomes following severe pediatric TBI.

Authors:  L E Schrieff-Elson; K G F Thomas; U K Rohlwink; A A Figaji
Journal:  Childs Nerv Syst       Date:  2015-09-04       Impact factor: 1.475

Review 6.  Contemporary view on neuromonitoring following severe traumatic brain injury.

Authors:  John F Stover
Journal:  World J Crit Care Med       Date:  2012-02-04

Review 7.  Monitoring of brain and systemic oxygenation in neurocritical care patients.

Authors:  Mauro Oddo; Julian Bösel
Journal:  Neurocrit Care       Date:  2014-12       Impact factor: 3.210

Review 8.  Aspects on the Physiological and Biochemical Foundations of Neurocritical Care.

Authors:  Carl-Henrik Nordström; Lars-Owe Koskinen; Magnus Olivecrona
Journal:  Front Neurol       Date:  2017-06-19       Impact factor: 4.003

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.